December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Modified Indocyanine Green For Experimental Choriocapillaris Photodynamic Therapy
Author Affiliations & Notes
  • R Jorge
    Ophthalmology Sch of Med Ribeirao Preto Ribeirao Preto Brazil
  • JA Cardillo
    Ophthalmology Sch of Med Ribeirao Preto Ribeirao Preto Brazil
  • RA Costa
    Ophthalmology Paulista Sch of Med Sao Paulo Brazil
  • LS Quirino
    Ophthalmology Sch of Med Ribeirao Preto Ribeirao Preto Brazil
  • ME Farah
    Ophthalmology Paulista Sch of Med Sao Paulo Brazil
  • SM T Nunes
    Chemistry FFCLRP Ribeirao Preto Brazil
  • AC Tedesco
    Chemistry FFCLRP Ribeirao Preto Brazil
  • Footnotes
    Commercial Relationships   R. Jorge, None; J.A. Cardillo, None; R.A. Costa, None; L.S. Quirino, None; M.E. Farah, None; S.M.T. Nunes, None; A.C. Tedesco, None.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 1298. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      R Jorge, JA Cardillo, RA Costa, LS Quirino, ME Farah, SM T Nunes, AC Tedesco; Modified Indocyanine Green For Experimental Choriocapillaris Photodynamic Therapy . Invest. Ophthalmol. Vis. Sci. 2002;43(13):1298.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:To compare the potential of indocyanine green (ICG) photodynamic therapy in occluding the albino rabbit choriocapillary layer using a modified ICG formulation (mICG) with a regular ICG in aqueous solution (aICG). Methods:A new ICG using a lipid polymeric emulsion was developed (mICG). Determination of singlet oxygen yield, aggregation capability and blood clearance of both aICG and mICG were determined by photobleaching and spectrophotometry. Fundus photography, fluorescein angiography, and light and transmission electron microscopy were used to compare the efficiency of PDT-induced phothrombosis using mICG, and aICG as the photosensitizer, and to assess the resultant collateral damage to the albino rabbit retina. The delivery system consisted of a modified infrared diode laser tuned to 810nm. Results:The mICG clearance process was slowed down as compared to the aICG. The incorporation of ICG in emulsion enhanced the yields of triplet formation in two times and inhibited the drug aggregation capability. Using a 10 mg/ml ICG dose, choriocapillary occlusion of the albino rabbit was achieved at a radiant exposure of 28J/cm2 with mICG and 56 J/cm2 with aICG. Damage to the neural retina was minimal. Only inner photoreceptor segments showed degeneration, probably secondary to choroidal ischemia. Bruch's membrane remained intact. Retinal pigment epithelium was invariably damaged, as seen with other photosensitizers. Conclusion:The use of mICG resulted in a higher half-time of ICG in blood, a lower aggregation capability, and a higher singlet oxygen quantum production when compared to aICG. The lower irradiance and fluence required to obtain choriocapillaris occlusion with this new formulation may prevent from collateral thermal damage and the confinement of ICG in the vascular compartment may enhance membrane targetability. These combined considerations point towards further study of PDT using mICG for the treatment of choroidal vascular disease.

Keywords: 516 photodynamic therapy • 308 age-related macular degeneration • 345 choroid 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×